Drug Development

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

Antibody-based drugs offer new mechanisms of action and greater specificity.

Fighting Bacterial Resistance with Biologics

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Using training devices may ease patient anxiety about using autoinjectors and prefilled syringes, potentially leading to improved patient adherence.

Autoinjector Training May Lead to Patient Adherence

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

FDA Commissioner Scott Gottlieb has been promoting drug market competition in recent months that includes new guidance documents and targeted advisories to support R&D of complex drugs and combination products. 

Regulatory Developments in Combination Products

The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.

NIBRT, Valitacell Aim to Validate New Analytical Technology

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

The University of South Australia is working to develop needle-free vaccines for Zika, chikingunya, and peanut allergy in a collaboration with Australian biotechnology company Sementis and Enesi Pharma, a United Kingdom-based pharmaceutical company.

International Partnership Aims to Develop Needle-free Vaccines

The vaccine producer announced an expansion to its Holly Springs, NC, manufacturing facility where it will increase production of its cell-based quadrivalent influenza vaccine.

Seqirus Announces $140-Million Expansion for Vaccine Facility

Pharmapack Europe expects further increases in innovation across packaging and drug delivery to mirror overall industry trends.

Pharmapack Expects Accelerated Growth in Drug Delivery and Packaging, Mirroring Overall Industry

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities. 

Manufacturing Challenges Limit Gene Therapy Development

The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.

Formulation and Drug Delivery